Cite
HARVARD Citation
Balboa Ramilo, A. et al. (2022). The tyrosine kinase inhibitor Bosutinib does not inhibit angiotensin II-induced abdominal aortic aneurysm: Validation of the importance of PDGFR and c-Kit tyrosine kinases by Imatinib. Atherosclerosis. pp. 68-69. [Online].